A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

Lignende værker

• The new cardioprotector Monohydroxyethylrutoside protects against doxorubicin-induced inflammatory effects in vitro
  af: Abou El Hassan, M A I, et al.
  Udgivet: (2003)
• Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells
  af: Bruynzeel, A M E, et al.
  Udgivet: (2007)
• Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice
  af: Bruynzeel, A M E, et al.
  Udgivet: (2007)
• Monohydroxyethylrutoside as protector against chronic doxorubicin-induced cardiotoxicity.
  af: van Acker, S. A., et al.
  Udgivet: (1995)
• The semisynthetic flavonoid monoHER sensitises human soft tissue sarcoma cells to doxorubicin-induced apoptosis via inhibition of nuclear factor-κB
  af: Jacobs, H, et al.
  Udgivet: (2011)